Sagimet Biosciences (SGMT) Competitors $7.31 -0.03 (-0.41%) Closing price 04:00 PM EasternExtended Trading$7.50 +0.19 (+2.59%) As of 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SGMT vs. TNGX, PHAR, IMTX, UPB, RLAY, TSHA, CRMD, URGN, RZLT, and ABUSShould you be buying Sagimet Biosciences stock or one of its competitors? The main competitors of Sagimet Biosciences include Tango Therapeutics (TNGX), Pharming Group (PHAR), Immatics (IMTX), Upstream Bio (UPB), Relay Therapeutics (RLAY), Taysha Gene Therapies (TSHA), CorMedix (CRMD), Urogen Pharma (URGN), Rezolute (RZLT), and Arbutus Biopharma (ABUS). These companies are all part of the "pharmaceutical products" industry. Sagimet Biosciences vs. Its Competitors Tango Therapeutics Pharming Group Immatics Upstream Bio Relay Therapeutics Taysha Gene Therapies CorMedix Urogen Pharma Rezolute Arbutus Biopharma Sagimet Biosciences (NASDAQ:SGMT) and Tango Therapeutics (NASDAQ:TNGX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and media sentiment. Is SGMT or TNGX more profitable? Sagimet Biosciences has a net margin of 0.00% compared to Tango Therapeutics' net margin of -599.11%. Sagimet Biosciences' return on equity of -39.88% beat Tango Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Sagimet BiosciencesN/A -39.88% -38.40% Tango Therapeutics -599.11%-79.72%-49.30% Does the media refer more to SGMT or TNGX? In the previous week, Sagimet Biosciences had 7 more articles in the media than Tango Therapeutics. MarketBeat recorded 9 mentions for Sagimet Biosciences and 2 mentions for Tango Therapeutics. Sagimet Biosciences' average media sentiment score of 0.53 beat Tango Therapeutics' score of 0.51 indicating that Sagimet Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sagimet Biosciences 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tango Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings and valuation, SGMT or TNGX? Sagimet Biosciences has higher earnings, but lower revenue than Tango Therapeutics. Tango Therapeutics is trading at a lower price-to-earnings ratio than Sagimet Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSagimet Biosciences$2M118.86-$45.57M-$1.83-3.99Tango Therapeutics$42.07M18.27-$130.30M-$1.33-5.20 Do institutionals and insiders hold more shares of SGMT or TNGX? 87.9% of Sagimet Biosciences shares are held by institutional investors. Comparatively, 79.0% of Tango Therapeutics shares are held by institutional investors. 14.7% of Sagimet Biosciences shares are held by insiders. Comparatively, 7.5% of Tango Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts prefer SGMT or TNGX? Sagimet Biosciences currently has a consensus target price of $25.67, suggesting a potential upside of 251.12%. Tango Therapeutics has a consensus target price of $10.50, suggesting a potential upside of 51.95%. Given Sagimet Biosciences' stronger consensus rating and higher possible upside, equities analysts plainly believe Sagimet Biosciences is more favorable than Tango Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sagimet Biosciences 1 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.71Tango Therapeutics 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more volatility & risk, SGMT or TNGX? Sagimet Biosciences has a beta of 3.23, suggesting that its stock price is 223% more volatile than the S&P 500. Comparatively, Tango Therapeutics has a beta of 1.67, suggesting that its stock price is 67% more volatile than the S&P 500. SummarySagimet Biosciences beats Tango Therapeutics on 14 of the 16 factors compared between the two stocks. Get Sagimet Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGMT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SGMT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SGMT vs. The Competition Export to ExcelMetricSagimet BiosciencesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$238.71M$3.36B$6.11B$10.56BDividend YieldN/A2.29%5.69%4.75%P/E Ratio-3.9921.5785.4827.60Price / Sales118.86475.96622.96139.48Price / CashN/A47.1237.9261.55Price / Book1.4410.1413.136.76Net Income-$45.57M-$52.31M$3.30B$275.88M7 Day Performance4.73%6.72%5.29%3.72%1 Month Performance3.98%15.01%9.94%10.22%1 Year Performance84.36%29.34%87.78%35.86% Sagimet Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SGMTSagimet Biosciences2.8689 of 5 stars$7.31-0.4%$25.67+251.1%+76.4%$238.71M$2M-3.998News CoverageAnalyst ForecastTNGXTango Therapeutics2.0051 of 5 stars$8.44-1.1%$10.50+24.4%+4.3%$949.05M$24.30M-6.3590Analyst ForecastPHARPharming Group2.3468 of 5 stars$14.29+3.6%$30.00+109.9%+74.6%$944.82M$339.84M-109.92280Positive NewsAnalyst ForecastShort Interest ↑Gap UpIMTXImmatics2.4558 of 5 stars$7.91+2.7%$15.00+89.6%-13.9%$935.94M$168.65M-12.17260Analyst ForecastUPBUpstream Bio1.9326 of 5 stars$17.34+0.5%$56.50+225.8%N/A$930.47M$2.72M0.0038News CoverageAnalyst ForecastRLAYRelay Therapeutics2.8551 of 5 stars$5.19+0.4%$16.50+217.9%-8.0%$891.37M$10.01M-2.66330Positive NewsTSHATaysha Gene Therapies2.5514 of 5 stars$3.16-2.8%$8.29+162.2%+138.4%$886.58M$8.33M-9.29180Analyst ForecastCRMDCorMedix2.926 of 5 stars$11.85+4.9%$18.00+51.9%+20.9%$882.07M$121.48M15.8030Analyst DowngradeGap UpURGNUrogen Pharma3.9259 of 5 stars$19.14+4.4%$32.00+67.2%+35.6%$848.48M$90.40M-5.77200Analyst ForecastRZLTRezolute2.697 of 5 stars$9.29-0.5%$14.50+56.1%+83.3%$848.18MN/A-9.5840Analyst ForecastABUSArbutus Biopharma1.6438 of 5 stars$4.46+1.1%$5.00+12.1%+15.0%$845.39M$6.17M-15.3890News CoveragePositive NewsAnalyst Forecast Related Companies and Tools Related Companies Tango Therapeutics Competitors Pharming Group Competitors Immatics Competitors Upstream Bio Competitors Relay Therapeutics Competitors Taysha Gene Therapies Competitors CorMedix Competitors Urogen Pharma Competitors Rezolute Competitors Arbutus Biopharma Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SGMT) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredThe 'Big Beautiful Bill' That Could Break AmericaOn July 4th, they celebrated the $3.4 trillion "One Big Beautiful Bill Act." What they didn't say? This bil...American Alternative | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sagimet Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
